Novel Technique for Box-Lesion Ablation of Atrial Fibrillation Combined with Off-Pump Coronary Surgery
暂无分享,去创建一个
[1] P. McCarthy,et al. Prevalence of atrial fibrillation before cardiac surgery and factors associated with concomitant ablation. , 2020, The Journal of thoracic and cardiovascular surgery.
[2] R. Damiano,et al. Surgical Ablation of Atrial Fibrillation in the United States: Trends and Propensity Matched Outcomes. , 2017, The Annals of thoracic surgery.
[3] H. Calkins,et al. Expert consensus guidelines: Examining surgical ablation for atrial fibrillation , 2017, The Journal of thoracic and cardiovascular surgery.
[4] Andrew D. Shaw,et al. Acute kidney injury following cardiac surgery: current understanding and future directions , 2016, Critical Care.
[5] A. Aidietis,et al. Long-term results of minimally invasive stand-alone bi-atrial surgical ablation with a bipolar ablation device for persistent and longstanding persistent AF: a single-center case series of 91 patients , 2016, Journal of Cardiothoracic Surgery.
[6] Da Zhu,et al. A novel "box lesion" minimally invasive totally thoracoscopic surgical ablation for atrial fibrillation. , 2015, Annals of the Academy of Medicine, Singapore.
[7] J. Doty,et al. Surgical Treatment of Isolated (Lone) Atrial Fibrillation with Gemini-S Ablation and Left Atrial Appendage Excision (GALAXY Procedure) , 2012, Innovations.
[8] R. Damiano,et al. Performance of the Cox‐maze IV procedure is associated with improved long‐term survival in patients with atrial fibrillation undergoing cardiac surgery , 2018, The Journal of thoracic and cardiovascular surgery.
[9] S. Bolling,et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. , 2017, The Annals of thoracic surgery.
[10] Mark T. Waters,et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution,andreproductioninanymedium,providedtheoriginalauthorandsourcearecredited.Thislicensedoesnot permit commercial exploitation or the creation of derivative works without sp , 2009 .